Page last updated: 2024-08-24

venlafaxine hydrochloride and Body Weight, Fetal

venlafaxine hydrochloride has been researched along with Body Weight, Fetal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berard, A; Ernest, SR; Hales, BF; Huang, C; Laurent, L; Vaillancourt, C	1

Other Studies

1 other study(ies) available for venlafaxine hydrochloride and Body Weight, Fetal

Article	Year
In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat. Birth defects research. Part A, Clinical and molecular teratology, 2016, Volume: 106, Issue:12 Topics: Administration, Oral; Animals; Female; Fetal Weight; Fetus; Fibroblast Growth Factor 8; Gene Expression; Heart; Heart Defects, Congenital; Litter Size; Male; Organ Size; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Venlafaxine Hydrochloride	2016

Article

Year

In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.

Birth defects research. Part A, Clinical and molecular teratology, 2016, Volume: 106, Issue:12

Topics: Administration, Oral; Animals; Female; Fetal Weight; Fetus; Fibroblast Growth Factor 8; Gene Expression; Heart; Heart Defects, Congenital; Litter Size; Male; Organ Size; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Venlafaxine Hydrochloride

2016